Filing Flows

Filing Flows › 8-K events › Amanat Acquisition

Amanat Acquisition: entry into a material definitive agreement

Form 8-K filed Oct 26, 2026 · items 1.01, 3.02, 7.01

Mergers and acquisitionsCorxel US and Amanat Acquisition Corp Announce Definitive Business Combination Agreement to Create Publicly Listed Obesity-Focused Biopharmaceutical Company

What the filing says

On October 25, 2026, Amanat Acquisition Corp, a Cayman Islands exempted company (“ AMAN ”), Cairo Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of AMAN (“ Merger Sub ”), Corxel Pharmaceuticals, Inc., a Delaware corporation (“ Corxel ”), and Corxel Pharmaceuticals Limited, a Cayman Islands exemp

Read the filing on SEC EDGAR →

What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 3.02: +0.1% next session across 2,750. Every item ranked →

What this kind of filing means

Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.

Other recent mergers and acquisitions

Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.